SCHEMBL19007866

SCHEMBL19007866

C=C(C)C(=O)OCCc1cc(-c2ccc(-c3ccc(C4CCC(CCCCC)CC4)cc3)c(C)c2)ccc1OCCO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 5/20 0.37
DGAT1 O75907 1/20 0.33
SOAT1 P35610 1/20 0.33
PPARA Q07869 2/20 0.33
PPARG P37231 1/20 0.33
RARB P10826 3/20 0.33
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
MMP9 P14780 1/20 0.32
MMP14 P50281 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 3/20 0.31
RAB9A P51151 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19796630 0.95 PPARD (0.38) PPARDDGAT1SOAT1PPARAPPARG
SCHEMBL19797012 0.95 PPARD (0.37) PPARDDGAT1SOAT1PPARAPPARG
SCHEMBL19007877 0.94 TSHR (0.34) PPARDDGAT1SOAT1PPARAPPARG
SCHEMBL17070423 0.91 PPARD (0.33) PPARDDGAT1SOAT1PPARAPPARG
SCHEMBL19796989 0.91 DGAT1 (0.33) PPARDDGAT1SOAT1RARBCYP2C9
SCHEMBL19797011 0.90 PPARD (0.37) PPARDPPARAPPARGRARBCYP2C9
SCHEMBL17070431 0.90 PPARD (0.33) PPARDDGAT1SOAT1PPARAPPARG
SCHEMBL19796632 0.90 PPARG (0.33) PPARDPPARAPPARGRARBTSHR
SCHEMBL19796638 0.90 TSHR (0.36) PPARDDGAT1SOAT1PPARAPPARG
SCHEMBL19797141 0.89 PPARA (0.34) PPARDDGAT1SOAT1PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10689576-B2 Liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-06-23 US disclosed
US-10385269-B2 Liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-08-20 US disclosed
US-20180208849-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-26 US disclosed
US-20180208849-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-26 US disclosed
EP-3327101-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2018-05-30 EP disclosed
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed
US-20170174993-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2017-06-22 US disclosed
US-20170174993-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 PPARD 3071/4885DGAT1 2685/4885SOAT1 1216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.